BioCryst Pharmaceuticals, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -3.33%75.850.0%$2404.81m
NVAXNovavax, Inc. 10.59%173.8299.2%$1290.59m
GILDGilead Sciences, Inc. -2.18%69.341.0%$528.36m
AMGNAmgen, Inc. -0.90%241.411.3%$511.00m
REGNRegeneron Pharmaceuticals, Inc. -3.23%627.472.5%$460.21m
SRNESorrento Therapeutics, Inc. 5.88%13.591.8%$441.61m
BNTXBioNTech SE -2.67%80.950.0%$401.86m
VRTXVertex Pharmaceuticals, Inc. -1.21%272.371.9%$379.92m
VXRTVaxart, Inc. 10.17%9.800.0%$329.85m
BIIBBiogen, Inc. -0.06%275.911.6%$326.72m
ILMNIllumina, Inc. 1.95%401.373.5%$326.19m
IBIOiBio, Inc. 0.57%4.421.8%$183.89m
EBSEmergent BioSolutions, Inc. 9.41%134.176.4%$177.05m
SGENSeattle Genetics, Inc. -1.15%163.176.1%$173.09m
ALXNAlexion Pharmaceuticals, Inc. -2.45%102.642.0%$170.67m

Company Profile

BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC.